Shilei Liu

875 total citations
39 papers, 498 citations indexed

About

Shilei Liu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shilei Liu has authored 39 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shilei Liu's work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Shilei Liu is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Shilei Liu collaborates with scholars based in China, United States and Canada. Shilei Liu's co-authors include Ziyi Yang, Wei Gong, Ping Dong, Yijun Shu, Xiangsong Wu, Fengnan Li, Wenjie Lv, Cheng Zhao, Wei Ma and Yidi Zhu and has published in prestigious journals such as Chemical Communications, CHEST Journal and Journal of Neurochemistry.

In The Last Decade

Shilei Liu

39 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shilei Liu China 15 305 134 118 85 84 39 498
Congcong Huang China 10 247 0.8× 152 1.1× 96 0.8× 36 0.4× 46 0.5× 26 460
Dimitris Karagiannis United States 8 376 1.2× 116 0.9× 116 1.0× 28 0.3× 52 0.6× 8 474
Eun Jeong Kwon South Korea 7 371 1.2× 121 0.9× 115 1.0× 32 0.4× 37 0.4× 9 538
Ezequiel Luis Calvo France 7 297 1.0× 86 0.6× 144 1.2× 77 0.9× 35 0.4× 8 463
Mohamed Bakr Zaki Egypt 16 559 1.8× 568 4.2× 84 0.7× 65 0.8× 36 0.4× 55 780
Mengqi Chang China 10 460 1.5× 210 1.6× 61 0.5× 30 0.4× 37 0.4× 17 575
Liangliang Dong China 11 305 1.0× 216 1.6× 35 0.3× 17 0.2× 97 1.2× 25 420
Shufang Mei China 12 436 1.4× 170 1.3× 59 0.5× 23 0.3× 35 0.4× 20 604

Countries citing papers authored by Shilei Liu

Since Specialization
Citations

This map shows the geographic impact of Shilei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilei Liu more than expected).

Fields of papers citing papers by Shilei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilei Liu. The network helps show where Shilei Liu may publish in the future.

Co-authorship network of co-authors of Shilei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shilei Liu. A scholar is included among the top collaborators of Shilei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilei Liu. Shilei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shilei, Sai Zhang, Liqiu Liao, et al.. (2024). Research progress on the multi-omics and survival status of circulating tumor cells. Clinical and Experimental Medicine. 24(1). 49–49. 7 indexed citations
2.
Jing, Qiang, Cheng Zhao, Shilei Liu, et al.. (2024). BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic target. Gene Therapy. 31(11-12). 594–606. 4 indexed citations
3.
Yang, Ziyi, Cheng Zhao, Shilei Liu, et al.. (2024). NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14. Cancer Letters. 587. 216703–216703. 4 indexed citations
4.
Liu, Shilei, Xiaoxiao Li, Sai Zhang, et al.. (2024). Identification of a lncRNA/circRNA-miRNA-mRNA network in Nasopharyngeal Carcinoma by deep sequencing and bioinformatics analysis. Journal of Cancer. 15(7). 1916–1928. 23 indexed citations
5.
Gao, Kun, Xianben Liu, Wenqun Xing, et al.. (2023). Treatment outcomes of surgery and chemotherapy for pulmonary metastases from non-lung cancers: a propensity score-matched analysis. Translational Cancer Research. 12(3). 585–594. 2 indexed citations
6.
Li, Keting, Xianben Liu, Yin Li, et al.. (2023). The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy. Journal of Cancer. 14(16). 3130–3138. 3 indexed citations
7.
Zhu, Yidi, Shilei Liu, Ziyi Yang, et al.. (2023). DNA methylation of RUNX3 promotes the progression of gallbladder cancer through repressing SLC7A11-mediated ferroptosis. Cellular Signalling. 108. 110710–110710. 14 indexed citations
8.
Zhao, Cheng, Ziyi Yang, Jian Zhang, et al.. (2022). Inhibition of XPO1 with KPT-330 induces autophagy-dependent apoptosis in gallbladder cancer by activating the p53/mTOR pathway. Journal of Translational Medicine. 20(1). 434–434. 15 indexed citations
9.
Yang, Ziyi, Shilei Liu, Ziyu Shao, et al.. (2022). Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy. Frontiers in Oncology. 12. 977963–977963. 14 indexed citations
10.
Ma, Wei, et al.. (2021). Integrated analysis of three newly sequenced fern chloroplast genomes: Genome structure and comparative analysis. Ecology and Evolution. 11(9). 4550–4563. 20 indexed citations
11.
Liu, Jindong, Jianxin Bian, Tao Jin, et al.. (2021). Identification of cold tolerance QTLs at the bud burst stage in 211 rice landraces by GWAS. BMC Plant Biology. 21(1). 542–542. 23 indexed citations
12.
Yao, Wenyan, et al.. (2021). Preoperative lymphocyte to C-reactive protein ratio as a new prognostic indicator in patients with resectable gallbladder cancer. Hepatobiliary & pancreatic diseases international. 21(3). 267–272. 13 indexed citations
13.
Yang, Ziyi, Tai Ren, Shilei Liu, et al.. (2021). Preoperative serum fibrinogen as a valuable predictor in the nomogram predicting overall survival of postoperative patients with gallbladder cancer. Journal of Gastrointestinal Oncology. 12(4). 1661–1672. 7 indexed citations
14.
Cheng, Qin, Peng Wang, Yanning Wang, et al.. (2021). Coordination of m6A mRNA methylation and gene transcriptome in rice response to cadmium stress. Rice. 14(1). 62–62. 49 indexed citations
15.
Li, Hang, Ting Ye, Bin Li, et al.. (2020). Is 99mTc bone scintigraphy necessary in the preoperative workup for patients with cT1N0 subsolid lung cancer? A prospective multicenter cohort study. Thoracic Cancer. 12(4). 415–419. 2 indexed citations
16.
Liu, Shilei, Bingfeng Chu, Xiangsong Wu, et al.. (2020). DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways. Journal of Cancer. 11(18). 5466–5477. 24 indexed citations
17.
Zheng, Yan, Xianben Liu, Ruixiang Zhang, et al.. (2019). Neoadjuvant chemotherapy followed by minimally invasive esophagectomy versus primary surgery for management of esophageal carcinoma: a retrospective study. Journal of Cancer. 10(5). 1097–1102. 11 indexed citations
18.
Wang, Zongfei, Li Yin, Shilei Liu, et al.. (2018). Application of vagus-sparing thoracolaparoscopic esophagectomy for esophageal cancer. 34(2). 82–83. 1 indexed citations
19.
Yu, Yongkui, Rui‐xiang Zhang, Haibo Sun, et al.. (2013). Tracheoesophageal fistula treated with esophageal exclusion and cervical esophago-gastric anastomosis via a retrosternal approach. Chinese Medical Journal. 126(9). 1800–1800. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Congcong Huang Breakdown of academic impact, for papers by Dimitris Karagiannis Breakdown of academic impact, for papers by Eun Jeong Kwon Breakdown of academic impact, for papers by Ezequiel Luis Calvo Breakdown of academic impact, for papers by Mohamed Bakr Zaki Breakdown of academic impact, for papers by Mengqi Chang Breakdown of academic impact, for papers by Liangliang Dong Breakdown of academic impact, for papers by Shufang Mei
Rankless by CCL
2026